A. Antón
Impact in
- Oncology top 2%
- Cancer Treatment and Pharmacology
- HER2/EGFR in Cancer Research
- Cancer Immunotherapy and Biomarkers
- Lung Cancer Research Studies
- Cancer Research top 5%
- Breast Cancer Treatment Studies
Papers in
-
- Breast Cancer Treatment Studies 23
- Cancer Genomics and Diagnostics 10
- Oncology 68
- Cancer Treatment and Pharmacology 31
- HER2/EGFR in Cancer Research 20
- Colorectal Cancer Treatments and Studies 14
- Co-authors
- Catherine M. KellyAňa LluchMiguel Ángel SeguíFilippo MontemurroRachel WuerstleinSuzette DelalogePeter EllisVicente Guillém
- Journals
- Journal of Clinical Oncology (25 papers)Annals of Oncology (20 papers)Clinical & Translational Oncology (8 papers)Cancer Research (7 papers)European Journal of Cancer (5 papers)
- Partner nations
- SpainAustraliaUnited States
In The Last Decade
A. Antón
100 papers receiving 1.7k citations
Hit Papers
Peers
Comparison fields: 5 of 83
- Oncology 1.3k
- Cancer Research 492
- Pulmonary and Respiratory Medicine 695
- Dermatology 76
- Radiology, Nuclear Medicine and Imaging 179
Countries citing papers authored by A. Antón
This map shows the geographic impact of A. Antón's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Antón with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Antón more than expected).
Fields of papers citing papers by A. Antón
This network shows the impact of papers produced by A. Antón. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Antón. The network helps show where A. Antón may publish in the future.
Co-authors
The 25 scholars most cited alongside A. Antón, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 0 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 1 | |
| 5 | 2023 | 7 | |
| 6 | 2023 | 0 | |
| 7 | 2023 | 1 | |
| 8 | Pathologic complete response (pCR) to neoadjuvant treatment with or without atezolizumab in triple-negative, early high-risk and locally advanced breast cancer: NeoTRIP Michelangelo randomized study Hit paper breakdown → | 2022 | 204 |
| 9 | 2022 | 2 | |
| 10 | 2021 | 8 | |
| 11 | 2021 | 3 | |
| 12 | 2021 | 14 | |
| 13 | 2020 | 12 | |
| 14 | 2019 | 4 | |
| 15 | 2017 | 13 | |
| 16 | 2013 | 9 | |
| 17 | 2012 | 11 | |
| 18 | 2010 | 27 | |
| 19 | 1998 | 4 | |
| 20 | 1998 | 50 |
About A. Antón
A. Antón is a scholar working on Cancer Research, Oncology, Pulmonary and Respiratory Medicine, Hepatology and Radiology, Nuclear Medicine and Imaging, having authored 103 papers that have together received 1.7k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (31 papers), Prostate Cancer Treatment and Research (24 papers), Breast Cancer Treatment Studies (23 papers), HER2/EGFR in Cancer Research (20 papers), Advanced Breast Cancer Therapies (16 papers), Radiopharmaceutical Chemistry and Applications (15 papers), Colorectal Cancer Treatments and Studies (14 papers) and Cancer Genomics and Diagnostics (10 papers). The work is most often cited by research in Oncology (1.3k citations), Cancer Research (492 citations), Pulmonary and Respiratory Medicine (695 citations), Dermatology (76 citations) and Radiology, Nuclear Medicine and Imaging (179 citations). A. Antón has collaborated with scholars based in Spain, Australia and United States. Frequent co-authors include Catherine M. Kelly, Aňa Lluch, Miguel Ángel Seguí, Filippo Montemurro, Rachel Wuerstlein, Suzette Delaloge, Peter Ellis, Vicente Guillém, Melek Tuğçe Yılmaz and Claudia Peña-Murillo. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Clinical & Translational Oncology, Cancer Research and European Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.